Robert Spraggins

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Instructor and Chief Resident

UAMS

Also affiliated: Louisiana State University (2021); Louisiana State University in Shreveport (2021); University of Arkansas Medical Center (2025); Central Arkansas Veterans Healthcare System (2026)

1 h-index 15 pubs 26 cited

Research Areas

OverviewAI-generated summary

Robert Spraggins' research focuses on cardiovascular outcomes and related health conditions, with a significant portion of his recent work examining real-world data. He has investigated the association between cardiovascular outcomes in individuals undergoing percutaneous coronary intervention, with or without preceding coronary CT angiography. His publications also address the efficacy of various therapeutic interventions, including SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes and in obese non-diabetic patients with metabolic dysfunction-associated steatotic liver disease. Spraggins has also explored cardiovascular outcomes of GLP-1RA therapy in specific patient populations and the comparative effectiveness of different lipid-lowering therapies. His work includes reviews on AI-enhanced ECG for acute coronary syndrome triage and analyses of cardiovascular outcomes in relation to post-traumatic stress disorder. He has also contributed to understanding QRS fragmentation morphology and early repolarization during the COVID-19 pandemic.

Metrics

h-index: 1
Publications: 15
Citations: 26

Positions

Instructor and Chief Resident publications 2023–2026

University of Arkansas for Medical Sciences Institution web page

Selected Publications

AI-enhanced ECG for acute coronary syndrome triage: A state-of-the-art review (2026)

Cardiovascular revascularization medicine DOI OpenAlex
Examining the association between cardiovascular outcomes in individuals undergoing percutaneous coronary intervention with or without a preceding coronary CT angiogram (2026)

European Heart Journal - Imaging Methods and Practice 1 citation DOI OpenAlex
26-A-11242-ACC REAL-WORLD CARDIOVASCULAR OUTCOMES OF COMBINED SGLT2 INHIBITOR AND GLP1 RECEPTOR AGONIST THERAPY IN TYPE 2 DIABETES INDIVIDUALS (2026)

Journal of the American College of Cardiology DOI OpenAlex
26-A-15959-ACC CARDIOVASCULAR OUTCOMES OF GLP-1RA THERAPY IN OBESE NON-DIABETIC PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: A REAL-WORLD ANALYSIS (2026)

Journal of the American College of Cardiology DOI OpenAlex
1200.03 Real-World Cardiovascular Outcomes of Inclisiran Versus PCSK9 Monoclonal Antibodies Therapy in Individuals with Hyperlipidemia (2026)

JACC: Cardiovascular Interventions DOI OpenAlex
Prevalence and Most Commonly Encountered QRS Fragmentation Morphology and Early Repolarization ST-Segment Changes During the Height of the COVID-19 Pandemic: A Single-Center Experience (2026)

Cureus DOI OpenAlex
HYPERTENSIVE RESPONSE DURING DOBUTAMINE STRESS ECHOCARDIOGRAPHY AND RISK OF NEW ONSET HEART FAILURE (2025)

Journal of the American College of Cardiology DOI OpenAlex
SIGNIFICANCE OF ISCHEMIC ELECTROCARDIOGRAM CHANGES IN THE SETTING OF NORMAL IMAGING IN DOBUTAMINE STRESS ECHOCARDIOGRAPHY (2025)

Journal of the American College of Cardiology DOI OpenAlex
Abstract 16061: Correlation Between Obesity and Ventricular Tachycardia in Individuals With HFrEF: Analysis From the DERIVATE Cohort (2023)

Circulation DOI OpenAlex